Ruth McKernan, AstronauTx co-founder (SV Health Investors)
October 9, 2023 06:47 AM EDT
Financing
Startups

No­var­tis, Bris­tol My­ers back $61M Se­ries A raise for de­men­tia biotech As­tro­nauTx

Ayisha Sharma

News Reporter

Big Phar­ma-sup­port­ed biotech As­tro­nauTx has bagged £48 mil­lion ($61 mil­lion) in a Se­ries A raise to ad­vance its pre­clin­i­cal pipeline of small-mol­e­cule drugs for neu­rode­gen­er­a­tive …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­vo Nordisk bud­gets $4.1B for new US man­u­fac­tur­ing site as it aban­dons plans for Irish build

Al­ny­lam’s RNAi ther­a­py suc­ceeds in close­ly-watched Phase 3 heart tri­al

Mer­ck KGaA's bet on head and neck can­cer drug from De­bio­pharm ends in Phase 3 fail­ure

Grail pre­pares for pub­lic de­but, and chal­lenges of go­ing in­de­pen­dent, af­ter spin­off from Il­lu­mi­na

Phase 3 breast can­cer fail­ure leads to staff cuts, stock drop at G1 Ther­a­peu­tics

Ko­rea-based Bridge Bio­ther­a­peu­tics clos­es Boston of­fice

A service from the Financial Times